Showing results (671-680 of 908) with videos related to

Sort By:
Pageof 91
Annals of Neurology|June 9, 1999
The postmigrational development of polymicrogyria documented by magnetic resonance imaging from 31 weeks' postconceptional ageT E Inder, P S Huppi, G P Zientara, et al.
Cardiovascular and Interventional Radiology|July 3, 2007
Strategies for the management of SVC stent migration into the right atriumJ D Taylor, E D Lehmann, A-M Belli, et al.
Social Cognitive and Affective Neuroscience|January 10, 2012
The development of emotion regulation: an fMRI study of cognitive reappraisal in children, adolescents and young adultsKateri McRae, James J Gross, Jochen Weber, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 13, 2011
Who uses snus? A study of Texas adolescentsAlexandra Loukas, Milena D Batanova, Cayley E Velazquez, et al.
Frontiers in Chemistry|July 21, 2023
A dual-core NMR system for field-cycling singlet assisted diffusion NMRThomas B R Robertson, Rose C Bannister, Topaz A A Cartlidge, et al.
British Journal of Clinical Pharmacology|January 1, 1990
The influence of levodopa on gastric emptying in manD R Robertson, A G Renwick, N D Wood, et al.
AIDS (London, England)|June 23, 2016
Neurocognition with maraviroc compared with tenofovir in HIVKevin R Robertson, Sachiko Miyahara, Anthony Lee, et al.
Plos One|June 11, 2014
HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional studyChristine M Kelly, Joep J van Oosterhout, Chisomo Ngwalo, et al.
Breast Cancer Research and Treatment|October 16, 2012
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' studyJohn F R Robertson, Justin P O Lindemann, Antonio Llombart-Cussac, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatmentA Howell, J F R Robertson, J Quaresma Albano, et al.
Pageof 91